Found: 6
Select item for more details and to access through your institution.
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 6, p. 1, doi. 10.1002/jmv.28868
- By:
- Publication type:
- Article
Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28186
- By:
- Publication type:
- Article
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 784, doi. 10.3390/vaccines12070784
- By:
- Publication type:
- Article
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1761, doi. 10.3390/vaccines11121761
- By:
- Publication type:
- Article
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1546, doi. 10.3390/jcm11061546
- By:
- Publication type:
- Article
SARS-CoV-2 OMICRON VIRAL LOAD DECREASE AFTER MONOCLONAL ANTIBODIES OR ANTIVIRALS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 222
- By:
- Publication type:
- Article